Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis

Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack of information in detail on how mitochondrial Lon regulates cancer metastasis through ROS production in the tumor microenvironment (TME). Our...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 474; pp. 138 - 150
Main Authors Kuo, Cheng-Liang, Chou, Han-Yu, Chiu, Yi-Chieh, Cheng, An Ning, Fan, Chi-Chen, Chang, Yu-Ning, Chen, Chung-Hsing, Jiang, Shih Sheng, Chen, Nien-Jung, Lee, Alan Yueh-Luen
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.04.2020
Elsevier Limited
Subjects
ROS
ROS
Online AccessGet full text
ISSN0304-3835
1872-7980
1872-7980
DOI10.1016/j.canlet.2020.01.019

Cover

Loading…
Abstract Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack of information in detail on how mitochondrial Lon regulates cancer metastasis through ROS production in the tumor microenvironment (TME). Our results show that elevated Lon promotes epithelial-mesenchymal transition (EMT) via ROS-dependent p38 and NF-κB-signaling. We further identified pyrroline-5-carboxylate reductase 1 (PYCR1) as a client of chaperone Lon, which induces mitochondrial ROS and EMT by Lon. Mitochondrial Lon induces ROS-dependent production of inflammatory cytokines, such as TGF-β, IL-6, IL-13, and VEGF-A, which consequently activates EMT, angiogenesis, and M2 macrophage polarization. In addition, Lon expression is induced upon the activation and M2 polarization of macrophages, which further promotes M2 macrophages to enhance the immunosuppressive microenvironment and metastatic behaviors in the TME. This raises the possibility that manipulation of the mitochondrial redox balance in the TME may serve as a therapeutic strategy to improve T cell function in cancer immunotherapy. •Mitochondrial Lon interacts with mitochondrial matrix enzyme PYCR1 to induce reactive oxygen species (ROS) production.•The inflammatory cytokines by Lon-ROS are released from cancer into the tumor microenvironment (TME) via p38-NF-κB signaling.•The chronic inflammation by Lon promotes cancer metastasis, vascular angiogenesis, and M2 macrophages polarization in the TME.•TGF-β, IL-6, IL-13, and VEGF-A induced by mitochondrial Lon promote M2 macrophage polarization in an autocrine manner.•Mitochondrial ROS stress by Lon promotes malignancies by changing the cytokine equilibrium into an immunosuppressive TME.
AbstractList Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack of information in detail on how mitochondrial Lon regulates cancer metastasis through ROS production in the tumor microenvironment (TME). Our results show that elevated Lon promotes epithelial-mesenchymal transition (EMT) via ROS-dependent p38 and NF-κB-signaling. We further identified pyrroline-5-carboxylate reductase 1 (PYCR1) as a client of chaperone Lon, which induces mitochondrial ROS and EMT by Lon. Mitochondrial Lon induces ROS-dependent production of inflammatory cytokines, such as TGF-β, IL-6, IL-13, and VEGF-A, which consequently activates EMT, angiogenesis, and M2 macrophage polarization. In addition, Lon expression is induced upon the activation and M2 polarization of macrophages, which further promotes M2 macrophages to enhance the immunosuppressive microenvironment and metastatic behaviors in the TME. This raises the possibility that manipulation of the mitochondrial redox balance in the TME may serve as a therapeutic strategy to improve T cell function in cancer immunotherapy.
Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack of information in detail on how mitochondrial Lon regulates cancer metastasis through ROS production in the tumor microenvironment (TME). Our results show that elevated Lon promotes epithelial-mesenchymal transition (EMT) via ROS-dependent p38 and NF-κB-signaling. We further identified pyrroline-5-carboxylate reductase 1 (PYCR1) as a client of chaperone Lon, which induces mitochondrial ROS and EMT by Lon. Mitochondrial Lon induces ROS-dependent production of inflammatory cytokines, such as TGF-β, IL-6, IL-13, and VEGF-A, which consequently activates EMT, angiogenesis, and M2 macrophage polarization. In addition, Lon expression is induced upon the activation and M2 polarization of macrophages, which further promotes M2 macrophages to enhance the immunosuppressive microenvironment and metastatic behaviors in the TME. This raises the possibility that manipulation of the mitochondrial redox balance in the TME may serve as a therapeutic strategy to improve T cell function in cancer immunotherapy. •Mitochondrial Lon interacts with mitochondrial matrix enzyme PYCR1 to induce reactive oxygen species (ROS) production.•The inflammatory cytokines by Lon-ROS are released from cancer into the tumor microenvironment (TME) via p38-NF-κB signaling.•The chronic inflammation by Lon promotes cancer metastasis, vascular angiogenesis, and M2 macrophages polarization in the TME.•TGF-β, IL-6, IL-13, and VEGF-A induced by mitochondrial Lon promote M2 macrophage polarization in an autocrine manner.•Mitochondrial ROS stress by Lon promotes malignancies by changing the cytokine equilibrium into an immunosuppressive TME.
Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack of information in detail on how mitochondrial Lon regulates cancer metastasis through ROS production in the tumor microenvironment (TME). Our results show that elevated Lon promotes epithelial-mesenchymal transition (EMT) via ROS-dependent p38 and NF-κB-signaling. We further identified pyrroline-5-carboxylate reductase 1 (PYCR1) as a client of chaperone Lon, which induces mitochondrial ROS and EMT by Lon. Mitochondrial Lon induces ROS-dependent production of inflammatory cytokines, such as TGF-β, IL-6, IL-13, and VEGF-A, which consequently activates EMT, angiogenesis, and M2 macrophage polarization. In addition, Lon expression is induced upon the activation and M2 polarization of macrophages, which further promotes M2 macrophages to enhance the immunosuppressive microenvironment and metastatic behaviors in the TME. This raises the possibility that manipulation of the mitochondrial redox balance in the TME may serve as a therapeutic strategy to improve T cell function in cancer immunotherapy.Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack of information in detail on how mitochondrial Lon regulates cancer metastasis through ROS production in the tumor microenvironment (TME). Our results show that elevated Lon promotes epithelial-mesenchymal transition (EMT) via ROS-dependent p38 and NF-κB-signaling. We further identified pyrroline-5-carboxylate reductase 1 (PYCR1) as a client of chaperone Lon, which induces mitochondrial ROS and EMT by Lon. Mitochondrial Lon induces ROS-dependent production of inflammatory cytokines, such as TGF-β, IL-6, IL-13, and VEGF-A, which consequently activates EMT, angiogenesis, and M2 macrophage polarization. In addition, Lon expression is induced upon the activation and M2 polarization of macrophages, which further promotes M2 macrophages to enhance the immunosuppressive microenvironment and metastatic behaviors in the TME. This raises the possibility that manipulation of the mitochondrial redox balance in the TME may serve as a therapeutic strategy to improve T cell function in cancer immunotherapy.
Author Cheng, An Ning
Chou, Han-Yu
Kuo, Cheng-Liang
Chiu, Yi-Chieh
Lee, Alan Yueh-Luen
Chang, Yu-Ning
Chen, Nien-Jung
Fan, Chi-Chen
Chen, Chung-Hsing
Jiang, Shih Sheng
Author_xml – sequence: 1
  givenname: Cheng-Liang
  surname: Kuo
  fullname: Kuo, Cheng-Liang
  organization: National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan
– sequence: 2
  givenname: Han-Yu
  surname: Chou
  fullname: Chou, Han-Yu
  organization: National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan
– sequence: 3
  givenname: Yi-Chieh
  surname: Chiu
  fullname: Chiu, Yi-Chieh
  organization: National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan
– sequence: 4
  givenname: An Ning
  surname: Cheng
  fullname: Cheng, An Ning
  organization: National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan
– sequence: 5
  givenname: Chi-Chen
  surname: Fan
  fullname: Fan, Chi-Chen
  organization: Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu, 30015, Taiwan
– sequence: 6
  givenname: Yu-Ning
  surname: Chang
  fullname: Chang, Yu-Ning
  organization: National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan
– sequence: 7
  givenname: Chung-Hsing
  surname: Chen
  fullname: Chen, Chung-Hsing
  organization: Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan
– sequence: 8
  givenname: Shih Sheng
  surname: Jiang
  fullname: Jiang, Shih Sheng
  organization: National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan
– sequence: 9
  givenname: Nien-Jung
  surname: Chen
  fullname: Chen, Nien-Jung
  organization: The Institute of Microbiology and Immunology, School of Life Sciences, National Yang-Ming University, Taipei, 11221, Taiwan
– sequence: 10
  givenname: Alan Yueh-Luen
  orcidid: 0000-0003-0252-0571
  surname: Lee
  fullname: Lee, Alan Yueh-Luen
  email: alanylee@nhri.edu.tw
  organization: National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31987921$$D View this record in MEDLINE/PubMed
BookMark eNqFkc2KFDEUhYOMOD2jbyAScOOm2qRSP4mIII1_0MOI6MJVSKVuOWkrSU-SauzHmDc2ZY-z6E3DDeHCdw6Xcy7QmfMOEHpOyZIS2rzeLLVyI6RlSUqyJDSPeIQWlLdl0QpOztCCMFIVjLP6HF3EuCGE1FVbP0HnjAreipIu0N2VSV7feNcHo0bs_5heJbMDHFOAGHG3x2vviq8_V98otsq4lF_EymFj7eR8nLbbGZwlabI-YGt08OB2JnhnwSWcblTC2-CtTxBxPlpDmPdf_3TeZbMeW0gq5jHxKXo8qDHCs_v_Ev34-OH76nOxvv70ZfV-XeiKi1QoJUQzdE0DXcs1qWhFhpoS0bUtJTVnPVe0aVTVcF13bGg4KQXVfa-7TgjOOnaJXh188ym3E8QkrYkaxlE58FOUJctZUV7yMqMvj9CNn4LL12WqLpmoBGsy9eKemjoLvdwGY1XYy_9hZ6A6ADmgGAMMDwglcu5UbuShUzl3KgnNI7LszZFMm5RL8i4FZcZT4ncHMeQodwaCjNpArqA3AXSSvTenDN4eGejROKPV-Bv2p-V_AazH1og
CitedBy_id crossref_primary_10_3389_fonc_2024_1446894
crossref_primary_10_3390_ijms22052252
crossref_primary_10_1136_jitc_2020_001372
crossref_primary_10_1155_2022_9683819
crossref_primary_10_18632_aging_205628
crossref_primary_10_3390_ijms232113370
crossref_primary_10_2139_ssrn_4387831
crossref_primary_10_3724_zdxbyxb_2023_0484
crossref_primary_10_22159_ijcpr_2022v14i2_1956
crossref_primary_10_1021_acsomega_2c07788
crossref_primary_10_1007_s00726_021_02961_5
crossref_primary_10_1007_s12032_020_01447_w
crossref_primary_10_1016_j_copbio_2023_103011
crossref_primary_10_3233_CBM_210329
crossref_primary_10_1002_adma_202305095
crossref_primary_10_3389_fimmu_2024_1483459
crossref_primary_10_3389_fimmu_2024_1374931
crossref_primary_10_3390_cells11233787
crossref_primary_10_1186_s13046_021_01889_8
crossref_primary_10_3390_ijms24054422
crossref_primary_10_11569_wcjd_v32_i1_23
crossref_primary_10_1038_s41419_023_05723_1
crossref_primary_10_3389_fimmu_2023_1224443
crossref_primary_10_1186_s12929_023_00956_w
crossref_primary_10_1615_CritRevEukaryotGeneExpr_2023049637
crossref_primary_10_1016_j_neo_2023_100919
crossref_primary_10_3390_ijms222111763
crossref_primary_10_1021_acsnano_1c04068
crossref_primary_10_1186_s12929_022_00859_2
crossref_primary_10_3390_antiox11081502
crossref_primary_10_1007_s00726_021_03047_y
crossref_primary_10_3389_fimmu_2024_1368685
crossref_primary_10_1002_arch_21785
crossref_primary_10_1136_jitc_2024_009409
crossref_primary_10_1038_s41423_023_00980_8
crossref_primary_10_1186_s13578_022_00747_0
crossref_primary_10_1186_s12935_024_03569_x
crossref_primary_10_1038_s41420_020_00341_8
crossref_primary_10_1080_21655979_2022_2052673
crossref_primary_10_1172_jci_insight_167395
crossref_primary_10_1186_s40001_023_01290_5
crossref_primary_10_1016_j_mito_2024_101977
crossref_primary_10_1158_0008_5472_CAN_23_0604
crossref_primary_10_3390_cancers14235723
crossref_primary_10_2147_OTT_S281450
crossref_primary_10_1152_ajpgi_00018_2023
crossref_primary_10_1016_j_isci_2024_110710
crossref_primary_10_1073_pnas_2416076121
crossref_primary_10_1111_jcmm_17637
crossref_primary_10_1007_s10555_023_10141_y
crossref_primary_10_1007_s00018_024_05556_x
crossref_primary_10_1007_s12672_025_01789_9
crossref_primary_10_1002_smll_202307390
crossref_primary_10_3892_or_2021_8159
crossref_primary_10_1016_j_clim_2023_109802
crossref_primary_10_1631_jzus_B2100930
crossref_primary_10_3390_ijms231810246
crossref_primary_10_1177_10732748241299072
crossref_primary_10_3389_fimmu_2023_1288137
crossref_primary_10_1002_med_21929
crossref_primary_10_1111_imm_13397
crossref_primary_10_1002_jgm_3527
crossref_primary_10_3389_fcell_2024_1405393
crossref_primary_10_1007_s00432_023_04983_w
crossref_primary_10_1038_s41568_021_00435_0
crossref_primary_10_1007_s00384_024_04686_9
crossref_primary_10_1007_s00726_021_02999_5
crossref_primary_10_3892_mmr_2022_12819
crossref_primary_10_1007_s00726_021_03048_x
crossref_primary_10_14348_molcells_2022_0115
crossref_primary_10_1002_adtp_202300265
crossref_primary_10_1007_s12094_024_03493_6
crossref_primary_10_3390_plants11243560
crossref_primary_10_3390_jpm13030488
crossref_primary_10_1016_j_colsurfb_2023_113353
crossref_primary_10_1016_j_bbcan_2024_189175
crossref_primary_10_2147_IJGM_S328109
crossref_primary_10_3389_fnut_2021_667643
crossref_primary_10_1038_s41577_022_00760_x
crossref_primary_10_1038_s41419_022_04668_1
crossref_primary_10_1038_s41598_023_37158_1
crossref_primary_10_1089_ars_2023_0272
crossref_primary_10_3389_fphar_2020_601785
crossref_primary_10_1186_s12951_024_02989_1
crossref_primary_10_1007_s00262_022_03255_9
crossref_primary_10_1186_s12943_024_02064_1
Cites_doi 10.1093/carcin/bgx022
10.1242/jcs.115.15.3193
10.4049/jimmunol.1402610
10.1681/ASN.2004050425
10.1016/j.cell.2007.09.007
10.1111/j.1349-7006.2010.01701.x
10.1089/ars.2012.5149
10.1016/j.freeradbiomed.2016.06.031
10.1038/s41556-018-0062-y
10.1016/j.tibs.2010.04.002
10.1016/j.ymeth.2007.10.004
10.1016/j.cell.2008.07.001
10.1016/j.cell.2007.01.047
10.1073/pnas.151236098
10.1089/ars.2011.4280
10.1007/s10555-010-9225-4
10.1186/1471-2164-9-302
10.1016/j.bbabio.2016.03.025
10.1007/s000180050029
10.1038/cddis.2015.9
10.1016/j.ceb.2016.07.010
10.2741/1667
10.1016/j.ccr.2009.03.016
10.1016/j.cell.2009.02.024
10.1089/152308602760598963
10.1172/JCI65385
10.2174/156800961603160206125352
10.1038/cr.2009.5
10.1016/j.celrep.2014.06.018
10.4049/jimmunol.179.10.7101
10.1016/j.immuni.2014.06.010
10.1038/s41580-018-0080-4
10.1189/jlb.0609385
10.1038/cddis.2013.204
10.1038/cddis.2016.105
10.1074/jbc.M117.780288
10.1016/j.redox.2015.09.009
10.1038/sj.onc.1206226
10.1038/ki.2014.205
10.1101/cshperspect.a000141
10.3389/fcell.2015.00023
10.1200/JCO.2012.46.3653
10.1038/nrc1256
10.1016/S0092-8674(00)81683-9
10.1038/nrc3803
10.1042/BJ20081386
10.1016/j.coi.2010.01.009
10.1038/nrm3758
10.1016/j.ccr.2009.01.023
10.1038/s41419-018-0730-7
10.1096/fj.14-255869
ContentType Journal Article
Copyright 2020 The Authors
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
2020. The Authors
Copyright_xml – notice: 2020 The Authors
– notice: Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
– notice: 2020. The Authors
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.canlet.2020.01.019
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-7980
EndPage 150
ExternalDocumentID 31987921
10_1016_j_canlet_2020_01_019
S0304383520300331
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations New York
Israel
United States--US
Taiwan
GeographicLocations_xml – name: Israel
– name: New York
– name: Taiwan
– name: United States--US
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
4.4
457
4CK
4G.
5GY
5RE
5VS
6J9
6PF
7-5
71M
8FE
8FH
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CS3
DU5
EBS
EFJIC
EFKBS
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IH2
IHE
J1W
K-O
KOM
LK8
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SPCBC
SSH
SSU
SSZ
T5K
Z5R
~G-
6I.
7RV
7X7
8C1
8FI
AACTN
AAFTH
AFCTW
AFKRA
AFKWA
AJOXV
AMFUW
AZQEC
BBNVY
BENPR
BHPHI
FYUFA
GUQSH
HCIFZ
M1P
M2M
M2O
M7P
.55
.GJ
3O-
53G
AAQXK
AAYXX
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
AFFNX
AFJKZ
AGQPQ
AGRDE
AGRNS
AI.
AIGII
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HED
HMK
HMO
HVGLF
HZ~
R2-
RIG
SAE
SEW
UDS
VH1
WUQ
X7M
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c489t-aa996fb66eb78c04140f5109b7710583d8a166a468c5b3f680291cddcbb9983b3
IEDL.DBID .~1
ISSN 0304-3835
1872-7980
IngestDate Fri Jul 11 11:01:14 EDT 2025
Wed Aug 13 11:37:23 EDT 2025
Thu Apr 03 07:05:39 EDT 2025
Tue Jul 01 02:29:40 EDT 2025
Thu Apr 24 22:55:36 EDT 2025
Tue Dec 03 03:45:22 EST 2024
Tue Aug 26 16:33:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords PYCR1
Immunoescape
Tumor microenvironment
Mitochondrial Lon
ROS
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c489t-aa996fb66eb78c04140f5109b7710583d8a166a468c5b3f680291cddcbb9983b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0252-0571
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0304383520300331
PMID 31987921
PQID 2352394936
PQPubID 2031080
PageCount 13
ParticipantIDs proquest_miscellaneous_2347518282
proquest_journals_2352394936
pubmed_primary_31987921
crossref_primary_10_1016_j_canlet_2020_01_019
crossref_citationtrail_10_1016_j_canlet_2020_01_019
elsevier_sciencedirect_doi_10_1016_j_canlet_2020_01_019
elsevier_clinicalkey_doi_10_1016_j_canlet_2020_01_019
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-04-01
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
– name: Clare
PublicationTitle Cancer letters
PublicationTitleAlternate Cancer Lett
PublicationYear 2020
Publisher Elsevier B.V
Elsevier Limited
Publisher_xml – name: Elsevier B.V
– name: Elsevier Limited
References Zhou, Kiosses, Liu, Schimmel (bib27) 2008; 44
Bota, Davies (bib24) 2016; 100
Xu, Lamouille, Derynck (bib31) 2009; 19
Chang, Poltoratsky, Vancurova (bib32) 2015; 194
Maouche, Poirier, Godefroy, Olaso, Gut, Collet, Montalescot, Cambien (bib35) 2008; 9
Murphy (bib15) 2009; 417
Christensen, Patel, Korasick, Campbell, Krause, Becker, Tanner (bib29) 2017; 292
Solimini, Luo, Elledge (bib5) 2007; 130
Solinas, Germano, Mantovani, Allavena (bib3) 2009; 86
Storz (bib28) 2005; 10
Sabharwal, Schumacker (bib9) 2014; 14
Mittal, Siddiqui, Tran, Reddy, Malik (bib10) 2014; 20
Wu, Deng, Rychahou, Qiu, Evers, Zhou (bib44) 2009; 15
Maulik (bib39) 2002; 4
Jain (bib1) 2013; 31
Mantovani, Sica (bib33) 2010; 22
Lo, Tseng, Tsao, Yang, Hsieh, Chiu, Takai, Mak, Tarng, Chen (bib26) 2014; 86
Rhyu, Yang, Ha, Lee, Song, Uh, Lee (bib14) 2005; 16
Sung, Kao, Kuo, Fan, Cheng, Fang, Chou, Lo, Chen, Jiang, Chang, Hsu, Lee, Lee (bib20) 2018; 9
Dongre, Weinberg (bib50) 2019; 20
Pesic, Greten (bib36) 2016; 43
Liu, Desai (bib40) 2015; 6
Cheng, Kuo, Fan, Fang, Jiang, Lo, Wang, Kao, Lee (bib18) 2013; 4
Pollard (bib48) 2004; 4
Fukuda, Zhang, Kim, Shimoda, Dang, Semenza (bib19) 2007; 129
Yeh, Hsu, Lee, Lang, Lin, Chang, Lee, Gu, Shih, Ho, Chen, Chen, Tu, Cheng, Chen, Yang, Jou (bib2) 2018; 20
Kudo-Saito (bib49) 2015; 3
Luo, Solimini, Elledge (bib4) 2009; 136
Quiros, Espanol, Acin-Perez, Rodriguez, Barcena, Watanabe, Calvo, Loureiro, Fernandez-Garcia, Fueyo, Vazquez, Enriquez, Lopez-Otin (bib22) 2014; 8
Karin (bib11) 2009; 1
Saha, Jana, Pahan (bib42) 2007; 179
Massague (bib12) 2008; 134
Chatterjee, Heukamp, Siobal, Schottle, Wieczorek, Peifer, Frasca, Koker, Konig, Meder, Rauh, Buettner, Wolf, Brekken, Neumaier, Christofori, Thomas, Ullrich (bib46) 2013; 123
Kudo-Saito, Shirako, Takeuchi, Kawakami (bib51) 2009; 15
Kao, Chiu, Fang, Cheng, Kuo, Juan, Wu, Lee (bib21) 2015; 6
Pinti, Gibellini, Nasi, De Biasi, Bortolotti, Iannone, Cossarizza (bib17) 2016; 1857
Tsai, Lee, Pan, Lee (bib34) 2016; 16
Hanahan, Weinberg (bib6) 2000; 100
Pani, Galeotti, Chiarugi (bib37) 2010; 29
Panieri, Santoro (bib7) 2016; 7
Wang, Cheng, Lin, Hsu, Fang, Hsu, Chiu, Chang, Hsu, Lee (bib25) 2010; 101
Ding, Kuo, Su, Xue, Luh, Zhang, Wang, Lin, Zhang, Chu, Zheng, Liu, Yen (bib30) 2017; 38
Lamouille, Xu, Derynck (bib13) 2014; 15
Wei, Kuo, Chen, Chou, Lai, Lee, Hsieh (bib45) 2003; 22
Hamanaka, Chandel (bib8) 2010; 35
Gibellini, Pinti, Boraldi, Giorgio, Bernardi, Bartolomeo, Nasi, De Biasi, Missiroli, Carnevale, Losi, Tesei, Pinton, Quaglino, Cossarizza (bib23) 2014; 28
Giannoni, Parri, Chiarugi (bib38) 2012; 16
Van Dyck, Langer (bib16) 1999; 56
Bakin, Rinehart, Tomlinson, Arteaga (bib41) 2002; 115
Shuto, Xu, Wang, Han, Kai, Gu, Murphy, Lim, Li (bib43) 2001; 98
Noy, Pollard (bib47) 2014; 41
Sabharwal (10.1016/j.canlet.2020.01.019_bib9) 2014; 14
Noy (10.1016/j.canlet.2020.01.019_bib47) 2014; 41
Pinti (10.1016/j.canlet.2020.01.019_bib17) 2016; 1857
Chatterjee (10.1016/j.canlet.2020.01.019_bib46) 2013; 123
Rhyu (10.1016/j.canlet.2020.01.019_bib14) 2005; 16
Tsai (10.1016/j.canlet.2020.01.019_bib34) 2016; 16
Solinas (10.1016/j.canlet.2020.01.019_bib3) 2009; 86
Cheng (10.1016/j.canlet.2020.01.019_bib18) 2013; 4
Chang (10.1016/j.canlet.2020.01.019_bib32) 2015; 194
Hamanaka (10.1016/j.canlet.2020.01.019_bib8) 2010; 35
Christensen (10.1016/j.canlet.2020.01.019_bib29) 2017; 292
Pollard (10.1016/j.canlet.2020.01.019_bib48) 2004; 4
Massague (10.1016/j.canlet.2020.01.019_bib12) 2008; 134
Sung (10.1016/j.canlet.2020.01.019_bib20) 2018; 9
Hanahan (10.1016/j.canlet.2020.01.019_bib6) 2000; 100
Dongre (10.1016/j.canlet.2020.01.019_bib50) 2019; 20
Fukuda (10.1016/j.canlet.2020.01.019_bib19) 2007; 129
Lo (10.1016/j.canlet.2020.01.019_bib26) 2014; 86
Quiros (10.1016/j.canlet.2020.01.019_bib22) 2014; 8
Mittal (10.1016/j.canlet.2020.01.019_bib10) 2014; 20
Wei (10.1016/j.canlet.2020.01.019_bib45) 2003; 22
Kudo-Saito (10.1016/j.canlet.2020.01.019_bib51) 2009; 15
Pani (10.1016/j.canlet.2020.01.019_bib37) 2010; 29
Kudo-Saito (10.1016/j.canlet.2020.01.019_bib49) 2015; 3
Wu (10.1016/j.canlet.2020.01.019_bib44) 2009; 15
Karin (10.1016/j.canlet.2020.01.019_bib11) 2009; 1
Lamouille (10.1016/j.canlet.2020.01.019_bib13) 2014; 15
Storz (10.1016/j.canlet.2020.01.019_bib28) 2005; 10
Ding (10.1016/j.canlet.2020.01.019_bib30) 2017; 38
Van Dyck (10.1016/j.canlet.2020.01.019_bib16) 1999; 56
Solimini (10.1016/j.canlet.2020.01.019_bib5) 2007; 130
Yeh (10.1016/j.canlet.2020.01.019_bib2) 2018; 20
Luo (10.1016/j.canlet.2020.01.019_bib4) 2009; 136
Kao (10.1016/j.canlet.2020.01.019_bib21) 2015; 6
Bota (10.1016/j.canlet.2020.01.019_bib24) 2016; 100
Panieri (10.1016/j.canlet.2020.01.019_bib7) 2016; 7
Mantovani (10.1016/j.canlet.2020.01.019_bib33) 2010; 22
Zhou (10.1016/j.canlet.2020.01.019_bib27) 2008; 44
Bakin (10.1016/j.canlet.2020.01.019_bib41) 2002; 115
Giannoni (10.1016/j.canlet.2020.01.019_bib38) 2012; 16
Gibellini (10.1016/j.canlet.2020.01.019_bib23) 2014; 28
Xu (10.1016/j.canlet.2020.01.019_bib31) 2009; 19
Saha (10.1016/j.canlet.2020.01.019_bib42) 2007; 179
Maulik (10.1016/j.canlet.2020.01.019_bib39) 2002; 4
Jain (10.1016/j.canlet.2020.01.019_bib1) 2013; 31
Pesic (10.1016/j.canlet.2020.01.019_bib36) 2016; 43
Shuto (10.1016/j.canlet.2020.01.019_bib43) 2001; 98
Murphy (10.1016/j.canlet.2020.01.019_bib15) 2009; 417
Maouche (10.1016/j.canlet.2020.01.019_bib35) 2008; 9
Liu (10.1016/j.canlet.2020.01.019_bib40) 2015; 6
Wang (10.1016/j.canlet.2020.01.019_bib25) 2010; 101
References_xml – volume: 417
  start-page: 1
  year: 2009
  end-page: 13
  ident: bib15
  article-title: How mitochondria produce reactive oxygen species
  publication-title: Biochem. J.
– volume: 15
  start-page: 416
  year: 2009
  end-page: 428
  ident: bib44
  article-title: Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion
  publication-title: Canc. Cell
– volume: 28
  start-page: 5122
  year: 2014
  end-page: 5135
  ident: bib23
  article-title: Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
  publication-title: Faseb. J.
– volume: 22
  start-page: 1517
  year: 2003
  end-page: 1527
  ident: bib45
  article-title: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
  publication-title: Oncogene
– volume: 100
  start-page: 57
  year: 2000
  end-page: 70
  ident: bib6
  article-title: The hallmarks of cancer
  publication-title: Cell
– volume: 38
  start-page: 519
  year: 2017
  end-page: 531
  ident: bib30
  article-title: Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers
  publication-title: Carcinogenesis
– volume: 20
  start-page: 1126
  year: 2014
  end-page: 1167
  ident: bib10
  article-title: Reactive oxygen species in inflammation and tissue injury
  publication-title: Antioxidants Redox Signal.
– volume: 16
  start-page: 275
  year: 2016
  end-page: 286
  ident: bib34
  article-title: The novel VEGF121-VEGF165 fusion attenuates angiogenesis and drug resistance via targeting VEGFR2-HIF-1alpha-VEGF165/Lon signaling through PI3K-AKT-mTOR pathway
  publication-title: Curr. Cancer Drug Targets
– volume: 56
  start-page: 825
  year: 1999
  end-page: 842
  ident: bib16
  article-title: ATP-dependent proteases controlling mitochondrial function in the yeast Saccharomyces cerevisiae
  publication-title: Cell. Mol. Life Sci.
– volume: 16
  start-page: 667
  year: 2005
  end-page: 675
  ident: bib14
  article-title: Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells
  publication-title: J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)
– volume: 8
  start-page: 542
  year: 2014
  end-page: 556
  ident: bib22
  article-title: ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity
  publication-title: Cell Rep.
– volume: 130
  start-page: 986
  year: 2007
  end-page: 988
  ident: bib5
  article-title: Non-oncogene addiction and the stress phenotype of cancer cells
  publication-title: Cell
– volume: 194
  start-page: 2942
  year: 2015
  end-page: 2953
  ident: bib32
  article-title: Bortezomib inhibits expression of TGF-beta1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells
  publication-title: J. Immunol.
– volume: 6
  start-page: 565
  year: 2015
  end-page: 577
  ident: bib40
  article-title: Reciprocal regulation of TGF-beta and reactive oxygen species: a perverse cycle for fibrosis
  publication-title: Redox Biol.
– volume: 15
  start-page: 178
  year: 2014
  end-page: 196
  ident: bib13
  article-title: Molecular mechanisms of epithelial-mesenchymal transition
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 35
  start-page: 505
  year: 2010
  end-page: 513
  ident: bib8
  article-title: Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes
  publication-title: Trends Biochem. Sci.
– volume: 86
  start-page: 1065
  year: 2009
  end-page: 1073
  ident: bib3
  article-title: Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
  publication-title: J. Leukoc. Biol.
– volume: 10
  start-page: 1881
  year: 2005
  end-page: 1896
  ident: bib28
  article-title: Reactive oxygen species in tumor progression
  publication-title: Front. Biosci. : J. Virt. Libr.
– volume: 101
  start-page: 2612
  year: 2010
  end-page: 2620
  ident: bib25
  article-title: Obtusilactone A and (-)-sesamin induce apoptosis in human lung cancer cells by inhibiting mitochondrial Lon protease and activating DNA damage checkpoints
  publication-title: Canc. Sci.
– volume: 20
  start-page: 479
  year: 2018
  end-page: 491
  ident: bib2
  article-title: PSPC1 mediates TGF-beta1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
  publication-title: Nat. Cell Biol.
– volume: 86
  start-page: 1174
  year: 2014
  end-page: 1186
  ident: bib26
  article-title: TREM-1 regulates macrophage polarization in ureteral obstruction
  publication-title: Kidney Int.
– volume: 292
  start-page: 7233
  year: 2017
  end-page: 7243
  ident: bib29
  article-title: Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1
  publication-title: J. Biol. Chem.
– volume: 98
  start-page: 8774
  year: 2001
  end-page: 8779
  ident: bib43
  article-title: Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 22
  start-page: 231
  year: 2010
  end-page: 237
  ident: bib33
  article-title: Macrophages, innate immunity and cancer: balance, tolerance, and diversity
  publication-title: Curr. Opin. Immunol.
– volume: 100
  start-page: 188
  year: 2016
  end-page: 198
  ident: bib24
  article-title: Mitochondrial Lon protease in human disease and aging: including an etiologic classification of Lon-related diseases and disorders
  publication-title: Free Radic. Biol. Med.
– volume: 129
  start-page: 111
  year: 2007
  end-page: 122
  ident: bib19
  article-title: HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells
  publication-title: Cell
– volume: 136
  start-page: 823
  year: 2009
  end-page: 837
  ident: bib4
  article-title: Principles of cancer therapy: oncogene and non-oncogene addiction
  publication-title: Cell
– volume: 123
  start-page: 1732
  year: 2013
  end-page: 1740
  ident: bib46
  article-title: Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
  publication-title: J. Clin. Invest.
– volume: 31
  start-page: 2205
  year: 2013
  end-page: 2218
  ident: bib1
  article-title: Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers
  publication-title: J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol.
– volume: 44
  start-page: 190
  year: 2008
  end-page: 195
  ident: bib27
  article-title: Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine
  publication-title: Methods
– volume: 179
  start-page: 7101
  year: 2007
  end-page: 7109
  ident: bib42
  article-title: MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65
  publication-title: J. Immunol.
– volume: 9
  start-page: 697
  year: 2018
  ident: bib20
  article-title: Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activity
  publication-title: Cell Death Dis.
– volume: 4
  start-page: 71
  year: 2004
  end-page: 78
  ident: bib48
  article-title: Tumour-educated macrophages promote tumour progression and metastasis
  publication-title: Nat. Rev. Canc.
– volume: 115
  start-page: 3193
  year: 2002
  end-page: 3206
  ident: bib41
  article-title: p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration
  publication-title: J. Cell Sci.
– volume: 134
  start-page: 215
  year: 2008
  end-page: 230
  ident: bib12
  article-title: TGFbeta in cancer
  publication-title: Cell
– volume: 9
  start-page: 302
  year: 2008
  ident: bib35
  article-title: Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells
  publication-title: BMC Genom.
– volume: 7
  start-page: e2253
  year: 2016
  ident: bib7
  article-title: ROS homeostasis and metabolism: a dangerous liason in cancer cells
  publication-title: Cell Death Dis.
– volume: 16
  start-page: 1248
  year: 2012
  end-page: 1263
  ident: bib38
  article-title: EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy
  publication-title: Antioxidants Redox Signal.
– volume: 3
  start-page: 23
  year: 2015
  ident: bib49
  article-title: Cancer-associated mesenchymal stem cells aggravate tumor progression
  publication-title: Front. Cell Dev. Biol.
– volume: 4
  start-page: e681
  year: 2013
  ident: bib18
  article-title: Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species
  publication-title: Cell Death Dis.
– volume: 6
  year: 2015
  ident: bib21
  article-title: Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex
  publication-title: Cell Death Dis.
– volume: 20
  start-page: 69
  year: 2019
  end-page: 84
  ident: bib50
  article-title: New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 15
  start-page: 195
  year: 2009
  end-page: 206
  ident: bib51
  article-title: Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells
  publication-title: Canc. Cell
– volume: 4
  start-page: 805
  year: 2002
  end-page: 815
  ident: bib39
  article-title: Redox signaling of angiogenesis
  publication-title: Antioxidants Redox Signal.
– volume: 43
  start-page: 55
  year: 2016
  end-page: 61
  ident: bib36
  article-title: Inflammation and cancer: tissue regeneration gone awry
  publication-title: Curr. Opin. Cell Biol.
– volume: 29
  start-page: 351
  year: 2010
  end-page: 378
  ident: bib37
  article-title: Metastasis: cancer cell's escape from oxidative stress
  publication-title: Canc. Metastasis Rev.
– volume: 41
  start-page: 49
  year: 2014
  end-page: 61
  ident: bib47
  article-title: Tumor-associated macrophages: from mechanisms to therapy
  publication-title: Immunity
– volume: 14
  start-page: 709
  year: 2014
  end-page: 721
  ident: bib9
  article-title: Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
  publication-title: Nat. Rev. Canc.
– volume: 1857
  start-page: 1300
  year: 2016
  end-page: 1306
  ident: bib17
  article-title: Emerging role of Lon protease as a master regulator of mitochondrial functions
  publication-title: Biochim. Biophys. Acta
– volume: 1
  year: 2009
  ident: bib11
  article-title: NF-kappaB as a critical link between inflammation and cancer
  publication-title: Cold Spring Harb. Perspect. Biol.
– volume: 19
  start-page: 156
  year: 2009
  end-page: 172
  ident: bib31
  article-title: TGF-beta-induced epithelial to mesenchymal transition
  publication-title: Cell Res.
– volume: 38
  start-page: 519
  year: 2017
  ident: 10.1016/j.canlet.2020.01.019_bib30
  article-title: Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgx022
– volume: 115
  start-page: 3193
  year: 2002
  ident: 10.1016/j.canlet.2020.01.019_bib41
  article-title: p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.115.15.3193
– volume: 194
  start-page: 2942
  year: 2015
  ident: 10.1016/j.canlet.2020.01.019_bib32
  article-title: Bortezomib inhibits expression of TGF-beta1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1402610
– volume: 16
  start-page: 667
  year: 2005
  ident: 10.1016/j.canlet.2020.01.019_bib14
  article-title: Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells
  publication-title: J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)
  doi: 10.1681/ASN.2004050425
– volume: 130
  start-page: 986
  year: 2007
  ident: 10.1016/j.canlet.2020.01.019_bib5
  article-title: Non-oncogene addiction and the stress phenotype of cancer cells
  publication-title: Cell
  doi: 10.1016/j.cell.2007.09.007
– volume: 101
  start-page: 2612
  year: 2010
  ident: 10.1016/j.canlet.2020.01.019_bib25
  article-title: Obtusilactone A and (-)-sesamin induce apoptosis in human lung cancer cells by inhibiting mitochondrial Lon protease and activating DNA damage checkpoints
  publication-title: Canc. Sci.
  doi: 10.1111/j.1349-7006.2010.01701.x
– volume: 20
  start-page: 1126
  year: 2014
  ident: 10.1016/j.canlet.2020.01.019_bib10
  article-title: Reactive oxygen species in inflammation and tissue injury
  publication-title: Antioxidants Redox Signal.
  doi: 10.1089/ars.2012.5149
– volume: 100
  start-page: 188
  year: 2016
  ident: 10.1016/j.canlet.2020.01.019_bib24
  article-title: Mitochondrial Lon protease in human disease and aging: including an etiologic classification of Lon-related diseases and disorders
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2016.06.031
– volume: 20
  start-page: 479
  year: 2018
  ident: 10.1016/j.canlet.2020.01.019_bib2
  article-title: PSPC1 mediates TGF-beta1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-018-0062-y
– volume: 35
  start-page: 505
  year: 2010
  ident: 10.1016/j.canlet.2020.01.019_bib8
  article-title: Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/j.tibs.2010.04.002
– volume: 44
  start-page: 190
  year: 2008
  ident: 10.1016/j.canlet.2020.01.019_bib27
  article-title: Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine
  publication-title: Methods
  doi: 10.1016/j.ymeth.2007.10.004
– volume: 134
  start-page: 215
  year: 2008
  ident: 10.1016/j.canlet.2020.01.019_bib12
  article-title: TGFbeta in cancer
  publication-title: Cell
  doi: 10.1016/j.cell.2008.07.001
– volume: 129
  start-page: 111
  year: 2007
  ident: 10.1016/j.canlet.2020.01.019_bib19
  article-title: HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells
  publication-title: Cell
  doi: 10.1016/j.cell.2007.01.047
– volume: 98
  start-page: 8774
  year: 2001
  ident: 10.1016/j.canlet.2020.01.019_bib43
  article-title: Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.151236098
– volume: 16
  start-page: 1248
  year: 2012
  ident: 10.1016/j.canlet.2020.01.019_bib38
  article-title: EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy
  publication-title: Antioxidants Redox Signal.
  doi: 10.1089/ars.2011.4280
– volume: 29
  start-page: 351
  year: 2010
  ident: 10.1016/j.canlet.2020.01.019_bib37
  article-title: Metastasis: cancer cell's escape from oxidative stress
  publication-title: Canc. Metastasis Rev.
  doi: 10.1007/s10555-010-9225-4
– volume: 9
  start-page: 302
  year: 2008
  ident: 10.1016/j.canlet.2020.01.019_bib35
  article-title: Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells
  publication-title: BMC Genom.
  doi: 10.1186/1471-2164-9-302
– volume: 1857
  start-page: 1300
  year: 2016
  ident: 10.1016/j.canlet.2020.01.019_bib17
  article-title: Emerging role of Lon protease as a master regulator of mitochondrial functions
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbabio.2016.03.025
– volume: 56
  start-page: 825
  year: 1999
  ident: 10.1016/j.canlet.2020.01.019_bib16
  article-title: ATP-dependent proteases controlling mitochondrial function in the yeast Saccharomyces cerevisiae
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s000180050029
– volume: 6
  year: 2015
  ident: 10.1016/j.canlet.2020.01.019_bib21
  article-title: Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2015.9
– volume: 43
  start-page: 55
  year: 2016
  ident: 10.1016/j.canlet.2020.01.019_bib36
  article-title: Inflammation and cancer: tissue regeneration gone awry
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2016.07.010
– volume: 10
  start-page: 1881
  year: 2005
  ident: 10.1016/j.canlet.2020.01.019_bib28
  article-title: Reactive oxygen species in tumor progression
  publication-title: Front. Biosci. : J. Virt. Libr.
  doi: 10.2741/1667
– volume: 15
  start-page: 416
  year: 2009
  ident: 10.1016/j.canlet.2020.01.019_bib44
  article-title: Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion
  publication-title: Canc. Cell
  doi: 10.1016/j.ccr.2009.03.016
– volume: 136
  start-page: 823
  year: 2009
  ident: 10.1016/j.canlet.2020.01.019_bib4
  article-title: Principles of cancer therapy: oncogene and non-oncogene addiction
  publication-title: Cell
  doi: 10.1016/j.cell.2009.02.024
– volume: 4
  start-page: 805
  year: 2002
  ident: 10.1016/j.canlet.2020.01.019_bib39
  article-title: Redox signaling of angiogenesis
  publication-title: Antioxidants Redox Signal.
  doi: 10.1089/152308602760598963
– volume: 123
  start-page: 1732
  year: 2013
  ident: 10.1016/j.canlet.2020.01.019_bib46
  article-title: Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI65385
– volume: 16
  start-page: 275
  year: 2016
  ident: 10.1016/j.canlet.2020.01.019_bib34
  article-title: The novel VEGF121-VEGF165 fusion attenuates angiogenesis and drug resistance via targeting VEGFR2-HIF-1alpha-VEGF165/Lon signaling through PI3K-AKT-mTOR pathway
  publication-title: Curr. Cancer Drug Targets
  doi: 10.2174/156800961603160206125352
– volume: 19
  start-page: 156
  year: 2009
  ident: 10.1016/j.canlet.2020.01.019_bib31
  article-title: TGF-beta-induced epithelial to mesenchymal transition
  publication-title: Cell Res.
  doi: 10.1038/cr.2009.5
– volume: 8
  start-page: 542
  year: 2014
  ident: 10.1016/j.canlet.2020.01.019_bib22
  article-title: ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.06.018
– volume: 179
  start-page: 7101
  year: 2007
  ident: 10.1016/j.canlet.2020.01.019_bib42
  article-title: MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.179.10.7101
– volume: 41
  start-page: 49
  year: 2014
  ident: 10.1016/j.canlet.2020.01.019_bib47
  article-title: Tumor-associated macrophages: from mechanisms to therapy
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.06.010
– volume: 20
  start-page: 69
  year: 2019
  ident: 10.1016/j.canlet.2020.01.019_bib50
  article-title: New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/s41580-018-0080-4
– volume: 86
  start-page: 1065
  year: 2009
  ident: 10.1016/j.canlet.2020.01.019_bib3
  article-title: Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0609385
– volume: 4
  start-page: e681
  year: 2013
  ident: 10.1016/j.canlet.2020.01.019_bib18
  article-title: Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2013.204
– volume: 7
  start-page: e2253
  year: 2016
  ident: 10.1016/j.canlet.2020.01.019_bib7
  article-title: ROS homeostasis and metabolism: a dangerous liason in cancer cells
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2016.105
– volume: 292
  start-page: 7233
  year: 2017
  ident: 10.1016/j.canlet.2020.01.019_bib29
  article-title: Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M117.780288
– volume: 6
  start-page: 565
  year: 2015
  ident: 10.1016/j.canlet.2020.01.019_bib40
  article-title: Reciprocal regulation of TGF-beta and reactive oxygen species: a perverse cycle for fibrosis
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2015.09.009
– volume: 22
  start-page: 1517
  year: 2003
  ident: 10.1016/j.canlet.2020.01.019_bib45
  article-title: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206226
– volume: 86
  start-page: 1174
  year: 2014
  ident: 10.1016/j.canlet.2020.01.019_bib26
  article-title: TREM-1 regulates macrophage polarization in ureteral obstruction
  publication-title: Kidney Int.
  doi: 10.1038/ki.2014.205
– volume: 1
  year: 2009
  ident: 10.1016/j.canlet.2020.01.019_bib11
  article-title: NF-kappaB as a critical link between inflammation and cancer
  publication-title: Cold Spring Harb. Perspect. Biol.
  doi: 10.1101/cshperspect.a000141
– volume: 3
  start-page: 23
  year: 2015
  ident: 10.1016/j.canlet.2020.01.019_bib49
  article-title: Cancer-associated mesenchymal stem cells aggravate tumor progression
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2015.00023
– volume: 31
  start-page: 2205
  year: 2013
  ident: 10.1016/j.canlet.2020.01.019_bib1
  article-title: Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers
  publication-title: J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol.
  doi: 10.1200/JCO.2012.46.3653
– volume: 4
  start-page: 71
  year: 2004
  ident: 10.1016/j.canlet.2020.01.019_bib48
  article-title: Tumour-educated macrophages promote tumour progression and metastasis
  publication-title: Nat. Rev. Canc.
  doi: 10.1038/nrc1256
– volume: 100
  start-page: 57
  year: 2000
  ident: 10.1016/j.canlet.2020.01.019_bib6
  article-title: The hallmarks of cancer
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81683-9
– volume: 14
  start-page: 709
  year: 2014
  ident: 10.1016/j.canlet.2020.01.019_bib9
  article-title: Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
  publication-title: Nat. Rev. Canc.
  doi: 10.1038/nrc3803
– volume: 417
  start-page: 1
  year: 2009
  ident: 10.1016/j.canlet.2020.01.019_bib15
  article-title: How mitochondria produce reactive oxygen species
  publication-title: Biochem. J.
  doi: 10.1042/BJ20081386
– volume: 22
  start-page: 231
  year: 2010
  ident: 10.1016/j.canlet.2020.01.019_bib33
  article-title: Macrophages, innate immunity and cancer: balance, tolerance, and diversity
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2010.01.009
– volume: 15
  start-page: 178
  year: 2014
  ident: 10.1016/j.canlet.2020.01.019_bib13
  article-title: Molecular mechanisms of epithelial-mesenchymal transition
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm3758
– volume: 15
  start-page: 195
  year: 2009
  ident: 10.1016/j.canlet.2020.01.019_bib51
  article-title: Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells
  publication-title: Canc. Cell
  doi: 10.1016/j.ccr.2009.01.023
– volume: 9
  start-page: 697
  year: 2018
  ident: 10.1016/j.canlet.2020.01.019_bib20
  article-title: Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activity
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-018-0730-7
– volume: 28
  start-page: 5122
  year: 2014
  ident: 10.1016/j.canlet.2020.01.019_bib23
  article-title: Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
  publication-title: Faseb. J.
  doi: 10.1096/fj.14-255869
SSID ssj0005475
Score 2.585456
Snippet Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 138
SubjectTerms Angiogenesis
Animals
Apoptosis
ATP-Dependent Proteases - genetics
ATP-Dependent Proteases - metabolism
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Cancer
Cancer immunotherapy
Carboxylate reductase
Carcinoma, Squamous Cell - immunology
Carcinoma, Squamous Cell - metabolism
Carcinoma, Squamous Cell - pathology
Cell activation
Cell Proliferation
Cytokines
delta-1-Pyrroline-5-Carboxylate Reductase
Epithelial-Mesenchymal Transition
Gene Expression Regulation, Neoplastic
Humans
Immunoescape
Immunoglobulins
Immunosuppressive agents
Immunotherapy
Inflammation
Interleukin 13
Interleukin 6
Laboratory animals
Lung Neoplasms - immunology
Lung Neoplasms - metabolism
Lung Neoplasms - secondary
Lymphocytes T
Macrophage Activation - immunology
Macrophages
Male
Melanoma - immunology
Melanoma - metabolism
Melanoma - pathology
Mesenchyme
Metabolism
Metastases
Metastasis
Mice
Mice, Inbred BALB C
Mice, Nude
Mitochondria
Mitochondria - metabolism
Mitochondria - pathology
Mitochondrial Lon
Mitochondrial Proteins - genetics
Mitochondrial Proteins - metabolism
Mouth Neoplasms - immunology
Mouth Neoplasms - metabolism
Mouth Neoplasms - pathology
NF-κB protein
Oxidative Stress
Polarization
Prognosis
Proteins
PYCR1
Pyrroline Carboxylate Reductases - genetics
Pyrroline Carboxylate Reductases - metabolism
Pyrroline-5-carboxylate reductase
Reactive oxygen species
Reactive Oxygen Species - metabolism
ROS
Tumor Cells, Cultured
Tumor Microenvironment
Vascular endothelial growth factor
Xenograft Model Antitumor Assays
Title Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0304383520300331
https://dx.doi.org/10.1016/j.canlet.2020.01.019
https://www.ncbi.nlm.nih.gov/pubmed/31987921
https://www.proquest.com/docview/2352394936
https://www.proquest.com/docview/2347518282
Volume 474
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_HCeKL-O3q3RHB17jtJk2Tx2Px2FP3EPXgfCpJmmIPt122XdCX-x_uP3YmaZcTlBOhD_3IlHxMJjOZ30wIeZ04r6rKGoapvJmoZMKsFJKVMvMKzzzKw9EJyzO5OBfvLrKLPTIfY2EQVjnI_ijTg7Qe3kyH3pyu63r6GZ16HBUIuEl4iKUWIkcuf3N1A-YhQrJdLMyw9Bg-FzBeUHvoHbASZ0lI3on5dv68PP1N_QzL0MkDcn_QH-lxrOJDsuebR-TucvCQPybXS5iiINKaEjmLtj_qMqT2pjEohNqf9EPbsI9f559SujJ1g1sDHTUNrTFSpO226wiNBZJ-u2o3dIWQvRvxcLT_Znq6DjA-31GHbLOhAecVc3zAz0q68r0BxbOruyfk_OTtl_mCDccuMCeU7pkxYANVVkpvc-USASZYBTNX2xy0kUzxUplUSiOkcpnllVTJTKeuLJ21YLtxy5-S_aZt_HNChTe5yVMtuFWgCpQmTxxHxIXPlbalnBA-9nbhhpzkeDTG92IEn10WcYwKHKMiSeHSE8J2VOuYk-OW8tk4kMUYbwoSsoBF4xa6fEf3G0_-A-XByC_FIBO6YgasyrXQHJr9avcZZjO6aEzj2y2WEegHAzt4Qp5FPts1keP-kJ6lL_67Wi_JPXyKwKMDst9vtv4QdKreHoVJc0TuHJ--X5z9AhCIIs8
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_HHqgv4rd7nhrB17DtJk3Tx2Px2PN2F9E7OJ9C0qZcxW2XbRfOP8P_2JkmXRWUE6EPpc2UfEwmM81vfiHkbZQ7VZbWMKTyZqKUEbNSSFbIxCk88yjtj05YruT8Ury_Sq4OyGzIhUFYZbD93qb31jo8mYTenGyqavIJN_U4OhBwE3HMpT5EdqpkRA5Pzs7nq59ID9Hz7WJ5hgJDBl0P84IGQAdBoDiNev5OpNz58wr1Nw-0X4lOH5D7wYWkJ76WD8mBqx-RO8uwSf6YfF_CLAWrVheoXLS5qYqe3Zv6vBBqv9FFU7MPn2cfY7o2VY1_B1pqalphskjT7jYeHQsi3W7dbOkaUXu_pMTR7tp0dNMj-VxLc9ScLe2hXp7mAz5W0LXrDPiebdU-IZen7y5mcxZOXmC5UFnHjIEwqLRSOpuqPBIQhZUweTObgkOSKF4oE0tphFR5YnkpVTTN4rwocmshfOOWPyWjuqndc0KFM6lJ40xwq8AbKEwa5RxBFy5VmS3kmPCht3UeaMnxdIyvesCffdF-jDSOkY5iuLIxYXupjafluKV8MgykHlJOwUhqWDdukUv3cr-p5T9IHg_6ooNZaPUUtJVnIuPQ7Df71zChcZfG1K7ZYRmBW2EQCo_JM69n-yZy_EWUTeOj_67Wa3J3frFc6MXZ6vwFuYdvPA7pmIy67c69BBers6_CFPoB7G8lgA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitochondrial+oxidative+stress+by+Lon-PYCR1+maintains+an+immunosuppressive+tumor+microenvironment+that+promotes+cancer+progression+and+metastasis&rft.jtitle=Cancer+letters&rft.au=Kuo%2C+Cheng-Liang&rft.au=Chou%2C+Han-Yu&rft.au=Chiu%2C+Yi-Chieh&rft.au=Cheng%2C+An+Ning&rft.date=2020-04-01&rft.issn=1872-7980&rft.eissn=1872-7980&rft.volume=474&rft.spage=138&rft_id=info:doi/10.1016%2Fj.canlet.2020.01.019&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3835&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3835&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3835&client=summon